Male

Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity
OBJECTIVE: To assess the predictive value of magnetic resonance imaging (MRI)-detected subclinical inflammation for subsequent …
Frédérique Gandjbakhch, Espen A. Haavardsholm, Philip G. Conaghan, Bo Ejbjerg, Violaine Foltz, Andrew K. Brown, Uffe Møller Døhn, Marissa Lassere, Jane E. Freeston, Inge Christoffer Olsen, Pernille Bøyesen, Paul Bird, Bruno Fautrel, Merete Lund Hetland, Paul Emery, Pierre Bourgeois, Kim Hørslev-Petersen, Tore K. Kvien, Fiona M. McQueen, Mikkel Østergaard
Cite DOI
Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study
BACKGROUND: Physical therapy is recommended for the management of axial spondyloarthritis (axSpA) and flexibility exercises have …
Silje Halvorsen Sveaas, Inger Jorid Berg, Sella Aarrestad Provan, Anne Grete Semb, Kåre Birger Hagen, Nina Vøllestad, Camilla Fongen, Inge C. Olsen, Annika Michelsen, Thor Ueland, Pål Aukrust, Tore K. Kvien, Hanne Dagfinrud
Cite DOI
Carotid plaque characteristics and disease activity in rheumatoid arthritis
OBJECTIVE: Carotid plaques (CP) are predictive of acute coronary syndrome in patients with rheumatoid arthritis (RA), suggesting that …
Anne G. Semb, Silvia Rollefstad, Sella A. Provan, Tore K. Kvien, Einar Stranden, Inge C. Olsen, Jonny Hisdal
Cite DOI
Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis
OBJECTIVE: Apolipoprotein E (APOE) genotypes are associated with cardiovascular disease (CVD) and lipid levels. In rheumatoid arthritis …
Marthe T. Maehlen, Sella A. Provan, Diederik P. C. de Rooy, Annette H. M. van der Helm-van Mil, Annemarie Krabben, Tore Saxne, Elisabet Lindqvist, Anne Grete Semb, Till Uhlig, Désirée van der Heijde, Inger Lise Mero, Inge C. Olsen, Tore K. Kvien, Benedicte A. Lie
Cite DOI
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
The clinical profile of ibandronate as add-on to calcitriol and calcium was studied in this double-blind, placebo-controlled trial of …
K. T. Smerud, S. Dolgos, I. C. Olsen, A. Åsberg, S. Sagedal, A. V. Reisæter, K. Midtvedt, P. Pfeffer, T. Ueland, K. Godang, J. Bollerslev, A. Hartmann
Cite DOI
ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial
OBJECTIVE: To investigate whether ω-3 fatty acids reduce magnetic resonance imaging (MRI) and clinical disease activity in patients …
Oivind Torkildsen, Stig Wergeland, Søren Bakke, Antonie G. Beiske, Kristian S. Bjerve, Harald Hovdal, Rune Midgard, Finn Lilleås, Tom Pedersen, Bård Bjørnarå, Frøydis Dalene, Grethe Kleveland, Jan Schepel, Inge Christoffer Olsen, Kjell-Morten Myhr
Cite DOI
Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure
AIMS: Myocardial 5-HT(4) serotonin (5-HT) receptors are increased and activated in heart failure (HF). Blockade of 5-HT(4) receptors …
John K. Kjekshus, Christian Torp-Pedersen, Lars Gullestad, Lars Køber, Thor Edvardsen, Inge C. Olsen, Ivar Sjaastad, Eirik Qvigstad, Tor Skomedal, Jan-Bjørn Osnes, Finn Olav Levy
Cite DOI
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
BACKGROUND: Treatment of relapsing-remitting multiple sclerosis with interferon beta is only partly effective, and new more effective …
Per Soelberg Sorensen, Svein Ivar Mellgren, Anders Svenningsson, Irina Elovaara, Jette Lautrup Frederiksen, Antonie Giaever Beiske, Kjell-Morten Myhr, Lise Vejby Søgaard, Inge Christoffer Olsen, Magnhild Sandberg-Wollheim
Cite DOI
Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia
BACKGROUND/AIMS: To evaluate the efficacy of oxcarbazepine (OXC) in the treatment of agitation and aggression in patients with …
Oskar H. Sommer, Olav Aga, Milada Cvancarova, Inge C. Olsen, Geir Selbaek, Knut Engedal
Cite DOI